125 related articles for article (PubMed ID: 25605153)
21. Mammographic predictors of the presence and size of invasive carcinomas associated with malignant microcalcification lesions without a mass.
Stomper PC; Geradts J; Edge SB; Levine EG
AJR Am J Roentgenol; 2003 Dec; 181(6):1679-84. PubMed ID: 14627596
[TBL] [Abstract][Full Text] [Related]
22. Clinical and pathological factors predictive of lymph node status in women with screen-detected breast cancer.
Gill PG; Luke CG; Roder DM
Breast; 2006 Oct; 15(5):640-8. PubMed ID: 16517164
[TBL] [Abstract][Full Text] [Related]
23. Normal Axillary Ultrasound Excludes Heavy Nodal Disease Burden in Patients with Breast Cancer.
Jackson RS; Mylander C; Rosman M; Andrade R; Sawyer K; Sanders T; Tafra L
Ann Surg Oncol; 2015 Oct; 22(10):3289-95. PubMed ID: 26224404
[TBL] [Abstract][Full Text] [Related]
24. Clinicopathologic characteristics of 143 patients with synchronous bilateral invasive breast carcinomas treated in a single institution.
Intra M; Rotmensz N; Viale G; Mariani L; Bonanni B; Mastropasqua MG; Galimberti V; Gennari R; Veronesi P; Colleoni M; Tousimis E; Galli A; Goldhirsch A; Veronesi U
Cancer; 2004 Sep; 101(5):905-12. PubMed ID: 15329896
[TBL] [Abstract][Full Text] [Related]
25. Screen-detected mucinous breast carcinoma: potential for delayed diagnosis.
Dhillon R; Depree P; Metcalf C; Wylie E
Clin Radiol; 2006 May; 61(5):423-30. PubMed ID: 16679116
[TBL] [Abstract][Full Text] [Related]
26. Relationships between age, mammographic features and pathological tumour characteristics in non-palpable breast cancer.
Ferranti C; Coopmans de Yoldi G; Biganzoli E; Bergonzi S; Mariani L; Scaperrotta G; Marchesini M
Br J Radiol; 2000 Jul; 73(871):698-705. PubMed ID: 11089459
[TBL] [Abstract][Full Text] [Related]
27. Nonpalpable breast carcinomas: long-term evaluation of 1,258 cases.
Veronesi U; Luini A; Botteri E; Zurrida S; Monti S; Galimberti V; Cassano E; Latronico A; Pizzamiglio M; Viale G; Vezzoli D; Rotmensz N; Musmeci S; Bassi F; Burgoa L; Maisonneuve P; Paganelli G; Veronesi P
Oncologist; 2010; 15(12):1248-52. PubMed ID: 21147866
[TBL] [Abstract][Full Text] [Related]
28. Correlation between hormone receptor status and age, and its prognostic implications in breast cancer patients in Bahrain.
AlZaman AS; Mughal SA; AlZaman YS; AlZaman ES
Saudi Med J; 2016 Jan; 37(1):37-42. PubMed ID: 26739972
[TBL] [Abstract][Full Text] [Related]
29. Breast microcalcifications: multivariate analysis of radiologic and clinical factors for carcinoma.
Fondrinier E; Lorimier G; Guerin-Boblet V; Bertrand AF; Mayras C; Dauver N
World J Surg; 2002 Mar; 26(3):290-6. PubMed ID: 11865363
[TBL] [Abstract][Full Text] [Related]
30. Is breast cancer from Sub Saharan Africa truly receptor poor? Prevalence of ER/PR/HER2 in breast cancer from Kenya.
Sayed S; Moloo Z; Wasike R; Bird P; Oigara R; Govender D; Kibera J; Carrara H; Saleh M
Breast; 2014 Oct; 23(5):591-6. PubMed ID: 25012047
[TBL] [Abstract][Full Text] [Related]
31. Malignant calcification is an important unfavorable prognostic factor in primary invasive breast cancer.
Ling H; Liu ZB; Xu LH; Xu XL; Liu GY; Shao ZM
Asia Pac J Clin Oncol; 2013 Jun; 9(2):139-45. PubMed ID: 22897789
[TBL] [Abstract][Full Text] [Related]
32. Different biological and prognostic breast cancer populations identified by FDG-PET in sentinel node-positive patients: results and clinical implications after eight-years follow-up.
Agresti R; Crippa F; Sandri M; Martelli G; Tagliabue E; Alessi A; Pellitteri C; Maccauro M; Maugeri I; Barbara P; Rampa M; Moscaroli A; Ferraris C; Carcangiu ML; Bianchi G; Greco M; Bombardieri E
Breast; 2014 Aug; 23(4):334-40. PubMed ID: 24485802
[TBL] [Abstract][Full Text] [Related]
33. Mucinous breast carcinoma showing as a cluster of suspicious microcalcifications on mammography.
Pina Insausti LJ; Soga Garcia E
Eur Radiol; 1998; 8(9):1666-8. PubMed ID: 9866783
[TBL] [Abstract][Full Text] [Related]
34. [Radiologic-histopathologic correlation of microcalcifications from 11g vacuum biopsy: analysis of 3196 core biopsies].
Fischmann A; Pietsch-Breitfeld B; Müller-Schimpfle M; Siegmann K; Wersebe A; Rothenberger-Janzen K; Claussen CD; Janzen J
Rofo; 2004 Apr; 176(4):538-43. PubMed ID: 15088178
[TBL] [Abstract][Full Text] [Related]
35. Do Calcifications Seen on Mammography After Neoadjuvant Chemotherapy for Breast Cancer Always Need to Be Excised?
Feliciano Y; Mamtani A; Morrow M; Stempel MM; Patil S; Jochelson MS
Ann Surg Oncol; 2017 Jun; 24(6):1492-1498. PubMed ID: 28058550
[TBL] [Abstract][Full Text] [Related]
36. Impact of neoadjuvant chemotherapy on pathologic axillary nodal status in HER-2 positive patients presenting with clinically node-negative disease.
Al-Hilli Z; Hieken TJ; Hoskin TL; Heins CN; Boughey JC
J Surg Oncol; 2015 Oct; 112(5):453-7. PubMed ID: 26345596
[TBL] [Abstract][Full Text] [Related]
37. Associations between the standardized uptake value of (18)F-FDG PET/CT and the prognostic factors of invasive lobular carcinoma: in comparison with invasive ductal carcinoma.
Jung NY; Kim SH; Choi BB; Kim SH; Sung MS
World J Surg Oncol; 2015 Mar; 13():113. PubMed ID: 25889560
[TBL] [Abstract][Full Text] [Related]
38. Mammographic finding as predictor of survival in 1-9 mm invasive breast cancers. worse prognosis for cases presenting as calcifications alone.
Thurfjell E; Thurfjell MG; Lindgren A
Breast Cancer Res Treat; 2001 May; 67(2):177-80. PubMed ID: 11519866
[TBL] [Abstract][Full Text] [Related]
39. BI-RADS 3-5 microcalcifications: prediction of lymph node metastasis of breast cancer.
Cen D; Xu L; Zhang S; Zhou S; Huang Y; Chen Z; Li N; Wang Y; Wang Q
Oncotarget; 2017 May; 8(18):30190-30198. PubMed ID: 28415815
[TBL] [Abstract][Full Text] [Related]
40. [Differences between clinical response and pathologic response of breast cancer after neoadjuvant chemotherapy].
Zheng S; Zhang BL; Zhang RZ; Yang JL; Zou SM; Xue LY; Luo W; Yuan YL; Lü N
Zhonghua Bing Li Xue Za Zhi; 2010 Nov; 39(11):734-8. PubMed ID: 21215162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
